Extending treatment after liver transplant may benefit patients with hepatitis C recurrence

(Henry Ford Health System) Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. “We found that patients who achieved a sustained virological response were more likely to have had extended treatment,” says Kimberly Brown, M.D., Division head of Gastroenterology at Henry Ford Hospital and senior author of the study.

source : www.eurekalert.org

Related News:

• Benign Prostatic Hyperplasia: Symptoms, Symptom Scores, And Outcome Measures
• Costs Of Adverse Events In First-Line Metastatic Renal Cell Carcinoma Treatment: Bevacizumab In Combination With Interferon-a2a Vs Sunitinib
• SIR: Low Event Rate with Stroke Prevention Device
• SIR: Pregnancy Possible After Fibroid Embolization
• SIR: Focused Ultrasound for Fibroids Effective Long-Term (CME/CE, with video)
• Designing A Tool For Operations On People With Severe Or Profound Auditory Loss
• ACC: Triglycerides Decreased with Rosuvastatin Therapy
• "Healthy" Snacks Loaded with Sugar and Salt
• Children with chronic respiratory illness are vulnerable to critical H1N1
• AAOS: Long-Term Benefit of Spine Fracture Tx Cited (CME/CE, with video)